Terms: = Uterine cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Staging
9 results:
1. Relationships between intravoxel incoherent motion parameters and expressions of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (pd-l1) in patients with cervical cancer.
Liu KH; Yang W; Tian HP
Clin Radiol; 2024 Feb; 79(2):e264-e272. PubMed ID: 37926648
[TBL] [Abstract] [Full Text] [Related]
2. [Expression and significance of immune checkpoint b7-homolog 4 in endometrial cancer].
Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
[No Abstract] [Full Text] [Related]
3. Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical cancer: an open-label, single-arm, phase II trial.
Chen J; Li C; Cao Y; Zhu L; Zhang B; You J; Hou H; Wang J; Yuan Z
BMC Cancer; 2022 Jul; 22(1):793. PubMed ID: 35854236
[TBL] [Abstract] [Full Text] [Related]
4. Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study.
Okonogi N; Usui H; Murata K; Hori M; Kurokawa T; Fujiwara T; Fujii Y; Hanawa M; Kawasaki Y; Hattori Y; Suzuki K; Tsuyuki K; Wakatsuki M; Hasegawa S; Yamada S; Hanaoka H; Shozu M; Tsuji H
BMJ Open; 2022 Mar; 12(3):e056424. PubMed ID: 35236732
[TBL] [Abstract] [Full Text] [Related]
5. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in uterine Corpus Endometrial Carcinoma.
Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J
Front Immunol; 2021; 12():788431. PubMed ID: 34970268
[TBL] [Abstract] [Full Text] [Related]
6. Treatment of gestational trophoblastic disease in the 2020s.
Clark JJ; Slater S; Seckl MJ
Curr Opin Obstet Gynecol; 2021 Feb; 33(1):7-12. PubMed ID: 33337613
[TBL] [Abstract] [Full Text] [Related]
7. Stabilization of Metastatic uterine Leiomyosarcoma Using Pembrolizumab.
Cotangco K; Meram M; Lowe MP
J Natl Compr Canc Netw; 2020 Aug; 18(8):1012-1014. PubMed ID: 32755974
[TBL] [Abstract] [Full Text] [Related]
8. Immunoscore system combining CD8 and PD-1/pd-l1: A novel approach that predicts the clinical outcomes for cervical cancer.
Chen H; Xia B; Zheng T; Lou G
Int J Biol Markers; 2020 Mar; 35(1):65-73. PubMed ID: 31808707
[TBL] [Abstract] [Full Text] [Related]
9. Immune Checkpoint Blockade in pd-l1-Positive Platinum-Refractory Cervical Carcinoma.
Tewari KS
J Clin Oncol; 2019 Jun; 37(17):1449-1454. PubMed ID: 31026210
[No Abstract] [Full Text] [Related]
